Fifteen-year trends in metastatic breast cancer survival in Greece

Breast Cancer Research and Treatment
U DafniG Fountzilas

Abstract

In the metastatic setting, a detected time trend to improved prognosis could be attributed to the corresponding recent advances in the therapeutic approaches. The aim of the current study was to first assess, in a large cohort of well over a thousand patients, the time trends in survival in MBC for the last 15 years and second to explore its association to prognostic factors affecting outcome including therapeutic regimen. This meta-analysis uses individual patient data collected from all the trials on MBC (6 nonrandomized, 4 randomized) conducted by HeCOG from 1991 through 2006. Four 4-year time periods (1991-1994, 1995-1998, 1999-2002, and 2003-2006) were constructed for exploration of time trends in survival according to the patient's date of metastatic diagnosis. Different first line regimens in the 10 trials include anthracycline monotherapy (epirubicin, in the early 1990s) and taxane containing regimens either as monotherapy or in different combinations with anthracyclines or other drugs. In two phase II studies and in the last randomized study, trastuzumab was administered in all the patients with HER2 overexpressing tumors. In this study, information is based on a total of 1361 patients with a median follow up of 3.7 ye...Continue Reading

References

Jan 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J J Shuster
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G FountzilasP Kosmidis
Mar 13, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FountzilasD Skarlos
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FountzilasD Skarlos
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Dec 24, 2003·Cancer·Sharon H GiordanoGabriel N Hortobagyi
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fabrice AndreMarc Spielmann
Feb 3, 2005·Statistics in Medicine·Catrin Tudur SmithAnthony G Marson
Feb 9, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FerlayP Boyle
Jul 22, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R LargillierE Chamorey
Aug 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shaheenah DawoodSharon H Giordano
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Apr 16, 2011·Breast Cancer : Basic and Clinical Research·Katherine H Rak Tkaczuk
Dec 26, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A C RegiererM B Wischnewsky
Nov 28, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M-P UfenA C Regierer
Feb 16, 2013·Breast Cancer Research and Treatment·Edoardo BotteriAron Goldhirsch
Apr 29, 2011·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Yoshinori ItoKiyohiko Hatake
Jul 7, 2015·The Breast : Official Journal of the European Society of Mastology·Grazia ArpinoSabino De Placido
Apr 5, 2015·The Breast : Official Journal of the European Society of Mastology·Angelo Di LeoMartine Piccart
May 30, 2015·Breast Cancer Research and Treatment·Ines Vaz-LuisRachel A Freedman
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Terence C ChuaDavid L Morris
Jun 28, 2016·Breast Cancer Research and Treatment·Christine LeopoldJ Frank Wharam
Aug 4, 2016·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Michael D'Angelica
Nov 7, 2016·The Breast : Official Journal of the European Society of Mastology·Catharina BartmannManfred Wischnewsky
Apr 30, 2015·Breast Cancer : Basic and Clinical Research·Simon B ZeichnerCharles L Vogel
Jan 15, 2018·Breast Cancer Research and Treatment·Philip D PoorvuMichael J Hassett
Sep 20, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Huzaifah SalatKhaled Abdel-Kader
Oct 8, 2013·Current Opinion in Oncology·Tom Wei-Wu Chen, Philippe L Bedard
Aug 16, 2018·World Journal of Surgical Oncology·Ryutaro MoriKazuhiro Yoshida
Apr 19, 2019·Antioxidants·Meenakshi SudhakaranAndrea I Doseff
Jan 11, 2019·JNCI Cancer Spectrum·Jennifer L Caswell-JinAllison W Kurian
Feb 8, 2013·American Journal of Clinical Oncology·Tamer RefaatWilliam Small
Sep 25, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·David P Al-AdraKymberly D Watt
Nov 19, 2020·Journal of Toxicology·Noah Kyame Asare-DonkorAnthony Apeke Adimado
Mar 23, 2021·Clinical Breast Cancer·Karen DailyAlexandra Thomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.